Hepatic encephalopathy is associated with posttransplant cognitive function and brain volume

Liver Transplantation

Volumn 17, Issue 1, 2011, Pages 38-46

  Garcia Martinez, Rita ^a,b   Rovira, Alex ^a   Alonso, Juli ^a,c   Jacas, Carlos ^a,b,c   Simõn Talero, MacArena ^a,b   Chavarria, Laia ^a,b,c   Vargas, Víctor ^a,b,c   Cõrdoba, Juan ^a,b,c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE; CREATINE PHOSPHATE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN SIZE; COGNITION; COGNITIVE DEFECT; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MOTOR PERFORMANCE; PRIORITY JOURNAL;

ADULT; ASPARTIC ACID; ATROPHY; BRAIN; CHI-SQUARE DISTRIBUTION; COGNITION; COGNITION DISORDERS; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; LINEAR MODELS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MOTOR SKILLS; NEUROPSYCHOLOGICAL TESTS; ORGAN SIZE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SPAIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 79251471107     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22197     Document Type: Article

References (35)

1. Buis CI, Wiesner RH, Krom RA, Kremers WK, Wijdicks EF., Acute confusional state following liver transplantation for alcoholic liver disease. Neurology 2002; 59: 601-605.
2. Ortiz M, Cordoba J, Jacas C, Flavia M, Esteban R, Guardia J., Neuropsychological abnormalities in cirrhosis include learning impairment. J Hepatol 2006; 44: 104-110.
3. Rose C, Jalan R., Is minimal hepatic encephalopathy completely reversible following liver transplantation? Liver Transpl 2004; 10: 84-87.
4. Mechtcheriakov S, Graziadei IW, Mattedi M, Bodner T, Kugener A, Hinterhuber HH, et al. Incomplete improvement of visuo-motor deficits in patients with minimal hepatic encephalopathy after liver transplantation. Liver Transpl 2004; 10: 77-83.
5. Sotil EU, Gottstein J, Ayala E, Randolph C, Blei AT., Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation. Liver Transpl 2009; 15: 184-192.
6. Cordoba J, Alonso J, Rovira A, Jacas C, Sanpedro F, Castells L, et al. The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol 2001; 35: 598-604.
7. Cordoba J, Raguer N, Flavia M, Vargas V, Jacas C, Alonso J, Rovira A,. T2 hyperintensity along the cortico-spinal tract in cirrhosis relates to functional abnormalities. HEPATOLOGY 2003; 38: 1026-1033.
8. Kril JJ, Butterworth RF., Diencephalic and cerebellar pathology in alcoholic and nonalcoholic patients with end-stage liver disease. HEPATOLOGY 1997; 26: 837-841.
9. Zeneroli ML, Cioni G, Vezzelli C, Grandi S, Crisi G, Luzietti R, et al. Prevalence of brain atrophy in liver cirrhosis patients with chronic persistent encephalopathy. Evaluation by computed tomography. J Hepatol 1987; 4: 283-292.
10. García Martínez R, Rovira A, Alonso J, Aymerich FX, Huerga E, Jacas C, et al. A long-term study of changes in the volume of brain ventricles and white matter lesions after successful liver transplantation. Transplantation 2010; 89: 589-594.
11. Bajaj JS, Schubert CM, Heuman DM, Wade JB, Gibson DP, Topaz A, et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology 2010; 138: 2332-2340.
12. Lezak MD, Howieson DB, Loring DW,. Neuropsychological Assessment. 4th ed. New York: Oxford University Press; 2004.
13. Randolph C, Hilsabeck R, Kato A, Kharbanda P, Li YY, Mapelli D, et al. Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 2009; 29: 629-635.
14. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT., Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. HEPATOLOGY 2002; 35: 716-721.
15. Smith SM, Zhang Y, Jenkinson M, Chen J, Matthews PM, Federico A, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002; 17: 479-489.
16. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004; 23 (Suppl 1): S208-S219.
17. Provencher SW., Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-679.
18. Hocking RR., The analysis and selection of variables in linear regression. Biometrics 1976; 32: 1-49.
19. Mallows CL., Some comments on Cp., Technometrics 1973; 15: 661-675.
20. Pujol A, Graus F, Rimola A, Beltran J, Garcia-Valdecasas JC, Navasa M, et al. Predictive factors of in-hospital CNS complications following liver transplantation. Neurology 1994; 44: 1226-1230.
21. Mattarozzi K, Stracciari A, Vignatelli L, D'Alessandro R, Morelli MC, Guarino M., Minimal hepatic encephalopathy: longitudinal effects of liver transplantation. Arch Neurol 2004; 61: 242-247.
22. Stracciari A, Guarino M, Pazzaglia P, Marchesini G, Pisi P., Acquired hepatocerebral degeneration: full recovery after liver transplantation. J Neurol Neurosurg Psychiatry 2001; 70: 136-137.
23. Servin-Abad L, Tzakis A, Schiff ER, Regev A., Acquired hepatocerebral degeneration in a patient with HCV cirrhosis: complete resolution with subsequent recurrence after liver transplantation. Liver Transpl 2006; 12: 1161-1165.
24. Atluri DK, Asgeri M, Mullen KD., Reversibility of hepatic encephalopathy after liver transplantation. Metab Brain Dis 2010; 25: 111-113.
25. Chick JD, Smith MA, Engleman HM, Kean DM, Mander AJ, Douglas RH, Best JJ,. Magnetic resonance imaging of the brain in alcoholics: cerebral atrophy, lifetime alcohol consumption, and cognitive deficits. Alcohol Clin Exp Res 1989; 13: 512-518.
26. O'Neill J, Cardenas VA, Meyerhoff DJ., Effects of abstinence on the brain: quantitative magnetic resonance imaging and magnetic resonance spectroscopic imaging in chronic alcohol abuse. Alcohol Clin Exp Res 2001; 25: 1673-1682.
27. Roberts RO, Geda YE, Knopman DS, Christianson TJ, Pankratz VS, Boeve BF, et al. Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol 2008; 65: 1066-1073.
28. Victor M, Adams RD, Cole M., The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine (Baltimore) 1965; 44: 345-396.
29. Shah NJ, Neeb H, Kircheis G, Engels P, Haussinger D, Zilles K., Quantitative cerebral water content mapping in hepatic encephalopathy. Neuroimage 2008; 41: 706-717.
30. Butterworth RF., Neuronal cell death in hepatic encephalopathy. Metab Brain Dis 2007; 22: 309-320.
31. Pfefferbaum A, Sullivan EV, Mathalon DH, Shear PK, Rosenbloom MJ, Lim KO., Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics. Alcohol Clin Exp Res 1995; 19: 1177-1191.
32. McCrea M, Cordoba J, Vessey G, Blei AT, Randolph C., Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Arch Neurol 1996; 53: 758-763.
33. Ehlenbach WJ, Hough CL, Crane PK, Haneuse SJ, Carson SS, Curtis JR, et al. Association between acute care and critical illness hospitalization and cognitive function in older adults. JAMA 2010; 303: 763-770.
34. Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med 2010; 362: 1071-1081.
35. Freeman RB Jr, Gish RG, Harper A, Davis GL, Vierling J, Lieblein L, et al. Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transpl 2006; 12 (Suppl 3): S128-S136.